StonvexLoading…
StonvexCore line items from PED's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $33.18M | $40.22M | $45.75M | $22.67M | $15.71M |
Operating Income | Not available | $6.70M | $-7.86M | $-2.93M | $-2.09M |
Net Income | Not available | $-25.63M | $-10.36M | $-1.86M | $-1.68M |
EPS (Diluted) | $0.40 | $-3.28 | $-2.25 | $-0.02 | $-0.02 |
Total Assets | Not available | $370.08M | $375.87M | $135.89M | $136.82M |
Total Liabilities | Not available | $187.90M | $168.50M | $20.52M | $16.17M |
Cash & Equivalents | Not available | $7.70M | $3.22M | $10.92M | $8.47M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 13.30M | 4.80M | 92.52M | 91.83M |